semaglutide for cardiovascular FDA Clears Cardiac Risk Reduction in Diabetic Patients Semaglutide Shows Secondary Cardiovascular Prevention

Patients and providers stress that abrupt discontinuation reverses hard-won progress in weight loss and health, risking a resurgence of diabetes, hypertension, sleep apnea, joint pain, and cardiovascular disease

Yam et al

A Comparison of Semaglutide, Tirzepatide, Liraglutide, and Phentermine for Weight Loss Compared to Diet and Exercise Alone FreshRx Dec 13, 2024 4 min read Weight loss medications like semaglutide, tirzepatide, liraglutide, and phentermine have gained significant attention for their potential to help individuals achieve and maintain weight loss

Los estudios disponibles sugieren aumentos modestos en los niveles de GLP-1 circulante, sin traducirse consistentemente en prdida de peso clnicamente significativa

291 , 1299113004 (2016) Wootten, D

Rascol O, OryMagne F, Meissner WG, Maltte D, Defebvre L, Azulay J, et al